The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 6, p. 2573, doi. 10.3892/ijo.2015.2961
- By:
- Publication type:
- Article